{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/malaria/management/management/","result":{"pageContext":{"chapter":{"id":"1e63a1a0-efe4-5864-b436-fdab0190793f","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 3d0d0de2-8c0f-4366-a7de-bc7faa46f2f2 --><h2>Scenario: Management</h2><!-- end field 3d0d0de2-8c0f-4366-a7de-bc7faa46f2f2 -->","summary":"Covers the management of suspected malaria in primary care including when to arrange immediate admission.","htmlStringContent":"<!-- begin item aa0f2bea-0cbe-471c-b9b8-52adfa888d97 --><!-- begin field e8541070-cfc9-4b6a-bc2b-acbd0088a2b1 --><p>From birth onwards.</p><!-- end field e8541070-cfc9-4b6a-bc2b-acbd0088a2b1 --><!-- end item aa0f2bea-0cbe-471c-b9b8-52adfa888d97 -->","topic":{"id":"a45cc869-8a29-5718-8d8c-fb4da11e3f58","topicId":"396f54ea-4a43-432a-964a-bf1c1d1ec304","topicName":"Malaria","slug":"malaria","lastRevised":"Last revised in November 2017","chapters":[{"id":"77ca73e7-67fc-5532-afdd-8a33d4f624bc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1d13888f-5984-5ba7-b602-28290217579c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"47353782-3c00-592f-bb46-5aed457f620b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c79fc9bf-9bf2-5be3-96a4-0e3a7b6c035d","slug":"changes","fullItemName":"Changes"},{"id":"170e13bf-3ada-54b4-b1da-bf3f2e576eff","slug":"update","fullItemName":"Update"}]},{"id":"edb18b0f-ecf6-511d-a62e-1a7193478cf6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e59bc905-80b7-59af-bcf3-18c542a8d661","slug":"goals","fullItemName":"Goals"},{"id":"016d9462-dbe7-5825-a4d6-41fc5e8d1de3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"712ad264-c3b5-5462-be1e-e09e84881fdd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"641a2f83-4b03-5455-8d1f-6d262c88ef45","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"beeed4d8-0061-5d53-9a52-4d9334fb0910","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4ec1d6f-3615-57b6-ae2a-adb55e52ea5d","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"b057ab2c-b9ca-5c35-835c-b6eae8d2496a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"498a864c-c278-5bde-b72a-027b19ecbc6e","slug":"definition","fullItemName":"Definition"},{"id":"13d57b0c-a8e8-5545-96f7-ee1a1c63e32a","slug":"causes","fullItemName":"Causes"},{"id":"866f277b-df2d-578d-b7d7-3a177101a324","slug":"prevalence","fullItemName":"Prevalence"},{"id":"706cfee4-7e61-51db-a06e-70897a85bb03","slug":"prognosis","fullItemName":"Prognosis"},{"id":"e7fbe927-f840-59a4-8e00-106c2834620c","slug":"complications","fullItemName":"Complications"}]},{"id":"0f19cdf2-1ae3-59f9-aa7e-5c62ccf99e0b","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"626cfe9a-1cdd-5ce1-b17e-aa5e34dfd463","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"945266cc-cfef-5b4f-8052-2fd55963fc95","slug":"assessment","fullItemName":"Assessment"},{"id":"8001a16a-f444-515d-868e-29a0fb3d528b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f44c57a5-21c7-5020-af41-0c1bce84d4fb","fullItemName":"Management","slug":"management","subChapters":[{"id":"1e63a1a0-efe4-5864-b436-fdab0190793f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"9fb3ee06-d5b5-5f13-91bd-eb4f5b931651","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bcaaf29e-dba5-5a1d-95af-f33c4cb8b1ab","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3a06d73b-b4d8-540e-b662-f35a7a79658a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26a9dace-bd47-561a-99a4-80a39ae3a7fc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"13eeb1d8-0198-54d8-92a2-1af0e30acbef","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7184569b-0bd0-580e-94f2-74fa8726805c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"724d6a34-a291-5477-a333-21be291a07cb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ed00be2d-b5e0-51b5-ade1-2acfd1171a2b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f44c57a5-21c7-5020-af41-0c1bce84d4fb","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"6447706c-8372-5879-9a9d-f9ceef9717b0","slug":"management-in-primary-care","fullItemName":"Management in primary care","depth":3,"htmlHeader":"<!-- begin field bb76a6fb-bd7b-495b-a054-9eaadaa54013 --><h3>Management of suspected malaria in primary care</h3><!-- end field bb76a6fb-bd7b-495b-a054-9eaadaa54013 -->","summary":null,"htmlStringContent":"<!-- begin item 1cc72863-6888-4235-8975-743cfb7102e5 --><!-- begin field b67d1306-2b46-4357-a918-553be6ae5cea --><p><strong>Malaria is a medical emergency:</strong></p><ul><li><strong>Arrange immediate admission for specialist assessment and <a class=\"topic-reference internal-reference\" href=\"/topics/malaria/management/management/#specialist-treatment-of-malaria\">treatment</a> if the person:</strong><ul><li>Is suspected of having severe or complicated malaria.</li><li>Is suspected of having falciparum malaria.</li><li>Is a pregnant woman.</li><li>Is a child.</li><li>Is older than 65 years of age.</li></ul></li><li><strong>Urgently discuss all other people suspected of having malaria with an infectious disease specialist </strong>— management practices vary according to local protocols and available expertise.<ul><li>In areas where capacity exists for clinical and parasitological monitoring (at least daily), clinicians experienced in the management of malaria may treat adults with malaria as outpatients. <ul><li>People with non-falciparum malaria may be admitted or observed for at least 8 hours after starting anti-malarial therapy.</li></ul></li><li>Additional advice on malaria for healthcare professionals is available from:<ul><li>The National Travel Health Network and Centre — urgent requests from health professionals can be discussed via a telephone advice service (Tel: 0845 602 6712).</li><li>The Hospital for Tropical Diseases, University College London Hospitals (available at <a data-hyperlink-id=\"344d2166-9d0e-41e2-a5d6-a93100c0cdf4\" href=\"http://www.thehtd.org/\" target=\"_blank\">www.thehtd.org</a>).</li><li><a data-hyperlink-id=\"1c1323be-8235-41f8-96ea-a93100c0ce03\" href=\"https://www.rlbuht.nhs.uk/departments/medical-specialisms/infection-and-immunology/tropical-and-infectious-diseases/\" target=\"_blank\">Tropical and Infectious Disease Unit</a>, Royal Liverpool University Hospital (available at <a data-hyperlink-id=\"0e5f9bd7-d7f1-4707-bb66-a93100c0ce15\" href=\"http://www.rlbuht.nhs.uk/\">www.rlbuht.nhs.uk</a>).</li></ul></li></ul></li><li><strong>Ensure that all cases of malaria have been notified to Public Health England</strong></li><li>Malaria is a notifiable disease and all cases of malaria should be notified to public health.</li><li><strong>Advise people who have been diagnosed with malaria:</strong><ul><li>To warn other members of their family or group they travelled with about the risk of malaria and advise them to seek immediate medical help if symptoms develop.</li><li>That an acute episode of malaria will not protect them from future attacks – they should seek pre-travel advice about avoidance of mosquito bites and malaria chemoprophylaxis for future trips to endemic areas.</li><li>That they will be notified to public health authorities as part of routine surveillance.</li><li>That relapses of malaria can occur (for example from failure of treatment due to drug resistance or poor absorption) and they should report any recurrence of symptoms such as fever.</li><li>That they will be excluded from blood donation for some time following malaria infection – blood donors should inform and discuss their specific situation with the National Blood Service.</li><li>That information on malaria for patients is available from:<ul><li>Public Health England — <a data-hyperlink-id=\"01828107-e679-4bf0-8ae7-a93100c0ced0\" href=\"https://www.gov.uk/government/publications/malaria-information-for-people-travelling-overseas\" target=\"_blank\">Malaria: information for people travelling overseas</a> (available at <a data-hyperlink-id=\"de30969f-2c85-47c4-9031-a93100c0ced0\" href=\"http://www.gov.uk/\" target=\"_blank\">www.gov.uk</a>).</li><li>Public Health England — <a data-hyperlink-id=\"a7d1feac-b392-4968-8169-a93100c0cf12\" href=\"https://www.gov.uk/government/publications/travelling-overseas-to-visit-friends-andrelatives-health-advice\" target=\"_blank\">Travelling overseas to visit friends and relatives</a> (available at <a data-hyperlink-id=\"52dac13d-2a7b-496a-af15-a93100c0cf18\" href=\"http://www.gov.uk/\">www.gov.uk</a>).</li><li>The Royal College of Obstetricians and Gynaecologists — <a data-hyperlink-id=\"edaaefc7-2853-4fdb-ad95-a93100c0cf1b\" href=\"https://www.rcog.org.uk/en/patients/patient-leaflets/malaria-and-pregnancy/\" target=\"_blank\">Malaria and pregnancy</a> (available at <a data-hyperlink-id=\"1de3f3d4-258a-4633-9ee7-a93100c0cf4a\" href=\"http://www.rcog.org.uk/\" target=\"_blank\">www.rcog.org.uk</a>).</li></ul></li></ul></li></ul><!-- end field b67d1306-2b46-4357-a918-553be6ae5cea --><!-- end item 1cc72863-6888-4235-8975-743cfb7102e5 -->","subChapters":[{"id":"a5be4a7f-56c9-5a10-8502-f7d2128506c1","slug":"specialist-treatment-of-malaria","fullItemName":"Specialist treatment of malaria","depth":4,"htmlHeader":"<!-- begin field 004ec0c2-687b-456c-979c-a6bd01034599 --><h4>What drugs are used to treat malaria?</h4><!-- end field 004ec0c2-687b-456c-979c-a6bd01034599 -->","summary":null,"htmlStringContent":"<!-- begin item 7ac84559-4257-45a8-ad93-a6bd01034539 --><!-- begin field 4d5e466b-c52f-46fe-a4d5-a6bd01034599 --><p><strong>Treatment of malaria depends on a variety of factors including species of Plasmodium parasite, severity of infection, tolerability of specific drugs and patterns of drug resistance. </strong></p><ul><li>Antimalarial drugs recommended in the UK malaria treatment guidelines 2016 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>] include:<ul><li><strong>Artesunate</strong><ul><li>Parenteral artesunate is used treat severe or complicated malaria.</li><li>Intravenous artesunate can cause haemolysis and follow-up blood tests are required.</li></ul></li><li><strong>Quinine</strong><ul><li>Quinine may be used initially to treat severe or complicated malaria if artesunate is unavailable.</li></ul></li><li><strong>Artemisinin combination therapy (ACT)</strong><ul><li>ACT may be used to treat uncomplicated malaria and is the preferred treatment for mixed infection.</li></ul></li><li><strong>Atovaquone-proguanil</strong> <ul><li>Atovaquone-proguanil may be used to treat uncomplicated falciparum malaria if ACT is unavailable.</li></ul></li><li><strong>Quinine plus doxycycline</strong><ul><li>A combination of quinine plus doxycycline may be used to treat uncomplicated falciparum malaria if ACT is unavailable.</li><li>Doxycycline should not be given to children younger than 12 years of age.</li></ul></li><li><strong>Chloroquine</strong><ul><li>Chloroquine may be used to treat uncomplicated <em>P. malariae</em>, <em>P. ovale</em> and <em>P. knowlesi </em>and most cases of <em>P. vivax</em> malaria but use depends upon patterns of resistance and tolerance.</li></ul></li><li><strong>Primaquine</strong><ul><li>Primaquine is the only currently effective drug for the eradication of hypnozoites (dormant parasites which persist in the liver after treatment of <em>P. vivax </em>and <em>P. ovale</em>).</li><li>Screening for G6PD deficiency is essential before treatment with primaquine is started as it can cause haemolysis in G6PD deficient individuals, which can be fatal. It is contraindicated in pregnancy and breastfeeding.</li></ul></li></ul></li><li>Overdose of antimalarial drugs, particularly chloroquine, can cause severe toxicity and be fatal.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">WHO, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>]</p><!-- end field 4d5e466b-c52f-46fe-a4d5-a6bd01034599 --><!-- end item 7ac84559-4257-45a8-ad93-a6bd01034539 -->","subChapters":[]},{"id":"451c0ee5-30c3-5ca6-8ca5-d7d05bac42e7","slug":"basis-for-recommendation-4fe","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0c977c0f-06b7-43c1-a121-2901e808c737 --><h4>Basis for recommendation</h4><!-- end field 0c977c0f-06b7-43c1-a121-2901e808c737 -->","summary":null,"htmlStringContent":"<!-- begin item 4fe5fc47-9fb6-4fa0-b33f-c689d24a8955 --><!-- begin field 9be4f3be-1ed0-49ef-87dc-f47fa49a6cb8 --><p>The recommendations on management of malaria in primary care are based on the clinical guidelines <em>The diagnosis and treatment of malaria in pregnancy. Green-top guideline</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">RCOG, 2010</a>], <em>Management of imported malaria in Europe</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">ESCMID, 2012</a>], <em>Canadian recommendations for the prevention and treatment of malaria</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHAC, 2014</a>], <em>Guidelines for the treatment of malaria</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">WHO, 2015</a>], <em>The Yellow Book: Chapter 5: General approach to the returned traveller. Fever in returned travellers</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">CDC, 2016b</a>] and <em>U</em><em>K malaria treatment guidelines 2016</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Feder, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Willcox, 2013</a>].</p><h5>Malaria is a medical emergency</h5><ul><li>Progression from asymptomatic infection to life-threatening malaria can be rapid, with severe complications and death occurring within 36 to 48 hours of onset of symptoms. The most important factors associated with patient survival are early diagnosis and appropriate treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Feder, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Willcox, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHAC, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li><li>Malaria-related mortality is higher in areas of the UK where malaria is less commonly managed.<ul><li>Twenty-six percent of malaria cases in the UK are seen in centres with less than 10 cases a year [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul></li></ul><h5>Admit all people with severe or complicated disease</h5><ul><li>People with severe or complicated disease are at risk of death and may need parenteral therapy and close clinical monitoring in a high dependency or intensive care unit [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHAC, 2014</a>].</li></ul><h5>Admit all people with suspected falciparum malaria</h5><ul><li>Admitting people with suspected falciparum malaria (for at least 24 hours) will ensure that treatment can be tolerated and that it is effectively reducing parasitaemia. Admission also allows rapid transfer to a high dependency or intensive care unit if the person’s condition rapidly deteriorates [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">PHAC, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].<ul><li>Any person with falciparum malaria (even those expected to be semi-immune) can deteriorate rapidly and require intensive care treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul></li><li>People with mixed infection including <em>P. falciparum</em> or with infection due to an unidentified Plasmodium species should be treated as for falciparum infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul><h5>Admit all pregnant women with suspected malaria</h5><ul><li>Women who are pregnant or in the post-partum period have an increased risk of malaria-related morbidity and mortality [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">RCOG, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">ESCMID, 2012</a>].</li><li><em>P. falciparum</em> malaria is more likely to lead to complications in pregnancy. Diagnosis can be difficult if parasites are concentrated in placenta and scanty in the blood — clinicians should have a low threshold for admission if malaria is suspected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li><li>Neonates whose mothers developed malaria in pregnancy require screening for malaria at birth and then weekly up to 28 days [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">RCOG, 2010</a>].</li></ul><h5>Admit all children with suspected malaria</h5><ul><li>The risk of life-threatening complications in malaria in children is high, close monitoring as an inpatient is recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Evans, 2010</a>].</li></ul><h5>Admit all people over age of 65 with suspected malaria</h5><ul><li>All older people with malaria should be admitted and monitored closely as the risk of mortality from falciparum and vivax malaria increases steadily with age over 65 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul><h5>Outpatient management of malaria may be considered in some cases</h5><ul><li>Management as outpatients may be considered in uncomplicated cases where facilities exist for daily clinical and parasitological monitoring until clearance of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">ESCMID, 2012</a>].</li><li>Malaria in people with malaria caused by <em>P. ovale</em>, <em>P. vivax</em>, and <em>P. malariae</em> who do not have other co-morbidities and can tolerate oral medication may be managed on an outpatient basis. However, clinicians should be aware that severe infections due to <em>P. knowlesi, P. vivax</em> and <em>P. ovale</em> can occur [<a class=\"bibliography-reference internal-reference\" href=\"/topics/malaria/references/\">Lalloo et al, 2016</a>].</li></ul><!-- end field 9be4f3be-1ed0-49ef-87dc-f47fa49a6cb8 --><!-- end item 4fe5fc47-9fb6-4fa0-b33f-c689d24a8955 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}